Using TAP block for pain relief after laparoscopic sleeve gastrectomy
Postoperative Efficacy of Subcostal TAP Block in Laparoscopic Sleeve Gastrectomy Surgery: a Randomized Controlled Trial
This study is testing if a special pain relief technique called the TAP block can help people feel less pain after laparoscopic sleeve gastrectomy while using fewer opioids.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Al-Azhar University Academic / other |
| Locations | 1 site (Cairo, Naser City) |
| Trial ID | NCT06156657 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of the subcostal transverse abdominis plane (TAP) block as a method for managing postoperative pain in patients undergoing laparoscopic sleeve gastrectomy. The approach aims to reduce reliance on opioids by utilizing an opioid-sparing technique that minimizes adverse effects associated with opioid use. The study will assess the analgesic benefits of the TAP block in conjunction with multimodal analgesia strategies, focusing on its ability to provide effective pain relief while avoiding complications related to traditional pain management methods.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 20-60 years with a BMI greater than 35 and classified as ASA I-II.
Not a fit: Patients who may not benefit from this study include those with allergies to the study drugs, infections at the injection site, or those who refuse participation.
Why it matters
Potential benefit: If successful, this approach could significantly improve postoperative pain management and reduce opioid-related side effects for patients undergoing bariatric surgery.
How similar studies have performed: Previous studies have shown promising results with TAP blocks in similar surgical contexts, indicating a growing interest in this technique for postoperative pain management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20-60 years * ASA Ι-ΙΙ * BMI \>35 Exclusion Criteria: * Patient refusal. * Allergy to study drugs. * Infection at site of injection.
Where this trial is running
Cairo, Naser City
- Al Azhar University — Cairo, Naser City, Egypt (Recruiting)
Study contacts
- Study coordinator: Ismail M Ahmed, prof
- Email: ismailabdelgawad.623@azhar.edu.eg
- Phone: 00201117310053
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.